XNYS
MED
Market cap127mUSD
Oct 08, Last price
11.43USD
1D
-0.09%
1Q
6.62%
Jan 2017
-72.54%
Name
Medifast Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Medifast, Inc., along with its subsidiary companies, specializes in the production and distribution of a diverse array of health and nutritional consumables. These offerings primarily focus on supporting weight loss, managing weight, and fostering overall healthy living across the United States and the Asia-Pacific region. The company's extensive product range encompasses nutritional bars, snack bites, pretzels, puffed snacks, cereals, various beverages, hearty meal alternatives, oatmeal, pancakes, puddings, soft-serve desserts, shakes, smoothies, baked goods, and soups. These items are prominently featured under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brand names. Sales of these products are facilitated through direct online transactions conducted via its e-commerce platform. Established in 1980, the firm maintains its corporate headquarters in Baltimore, Maryland.
Key people
Daniel Chard
Non-Executive Chairman of the Board · since 2026
James Maloney
Chief Financial Officer · since 2021
Claudia Greninger
Chief Human Resources Officer · since 2024
Jonathan Mackenzie
Chief Accounting Officer, Vice President - Finance · since 2021
Nicholas Johnson
President, Chief Executive Officer · since 2026
Chief Legal Officer, Corporate Secretary · since 2024
Lead Independent Director · since 2015
Elizabeth Geary
Independent Director · since 2022
Independent Director · since 2018
Scott Schlackman
Independent Director · since 2015
Andrea Thomas
Independent Director · since 2019
Ming Xian
Independent Director · since 2018
Legal address
c/o Corporate Creations Network Inc., 3411 Silverside Road Tatnall Building STE 104
Wilmington, DE 19810
US
Wilmington, DE 19810
US
Headquarters
100 International Drive, 18th Floor
Baltimore, MD 21202
US
Baltimore, MD 21202
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||